Peng Ling, Wang Ying, Fei Shihong, Wei Chunhua, Tong Fan, Wu Gang, Ma Hong, Dong Xiaorong
Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Transl Lung Cancer Res. 2020 Jun;9(3):745-760. doi: 10.21037/tlcr-20-500.
Combining Endostar (ES) with radiotherapy (RT) has shown a promising therapeutic effect on non-small cell lung carcinoma with brain metastases (BMs) in clinical practice. However, the specific mechanism is not yet fully understood. The present study aimed to investigate the effects of ES on blood vessels, tumor-associated macrophages (TAMs), and T cells in a tumor microenvironment treated with RT.
BM models were established by stereotactic and intracarotid injection of luciferase-Lewis lung cancer (LLC) cells into female C57BL mice. The animals were randomly divided into 4 groups: normal saline (NS), ES, RT, and ES plus radiotherapy (ES + RT) groups. Tumor size was determined with the IVIS imaging system. Tumor specimens were stained with CD34 and α-SMA to investigate tumor vascular changes. The proportions of TAMs, CD4 T cells, and CD8 T cells in tumor tissues were determined by flow cytometry and immunofluorescence. The expressions of hypoxia-inducible factor 1α (HIF-1α) and CXCR4 were deduced using western blotting and immunohistochemistry (IHC).
ES + RT significantly suppressed tumor growth compared to the other 3 groups. RT decreased M1 and increased M2 in microglial cells and bone marrow-derived macrophages (BMDMs) relative to NS, while ES had the opposite effect. The ratio of CD8T/CD4T was increased in the ES + RT group compared to the other 3 groups. Tumor vascular maturity (α-SMA/CD34) was increased while HIF-1α was significantly suppressed in the ES + RT group. CXCR4 expression, which is involved in TAM recruitment, increased following RT, whereas, ES attenuated its expression.
Our findings suggest that ES can promote the normalization of tumor blood vessels and increase the anti-tumor immune-related immune cells infiltrating the tumor following RT treatment.
在临床实践中,恩度(ES)联合放射治疗(RT)对非小细胞肺癌脑转移(BMs)显示出有前景的治疗效果。然而,其具体机制尚未完全明确。本研究旨在探讨ES对接受RT治疗的肿瘤微环境中的血管、肿瘤相关巨噬细胞(TAM)和T细胞的影响。
通过立体定向和经颈动脉向雌性C57BL小鼠注射荧光素酶 - 刘易斯肺癌(LLC)细胞建立BM模型。将动物随机分为4组:生理盐水(NS)组、ES组、RT组和ES联合放射治疗(ES + RT)组。用IVIS成像系统测定肿瘤大小。用CD34和α - SMA对肿瘤标本进行染色以研究肿瘤血管变化。通过流式细胞术和免疫荧光法测定肿瘤组织中TAM、CD4 T细胞和CD8 T细胞的比例。采用蛋白质印迹法和免疫组织化学(IHC)法推断缺氧诱导因子1α(HIF - 1α)和CXCR4的表达。
与其他3组相比,ES + RT显著抑制肿瘤生长。相对于NS组,RT使小胶质细胞和骨髓来源的巨噬细胞(BMDM)中的M1减少而M2增加,而ES则具有相反的作用。与其他3组相比,ES + RT组中CD8T/CD4T的比例增加。ES + RT组中肿瘤血管成熟度(α - SMA/CD34)增加,而HIF - 1α被显著抑制。参与TAM募集的CXCR4表达在RT后增加,而ES减弱了其表达。
我们的研究结果表明,ES可促进肿瘤血管正常化,并增加RT治疗后浸润肿瘤的抗肿瘤免疫相关免疫细胞。